BioSpace News Archive

Oxurion NV announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows:

Medidata, a Dassault Systèmes company, will be leading multiple sessions at the upcoming Summit for Clinical Ops Executives (SCOPE) on trial diversity, risk based quality management (RBQM), decentralized clinical trials (DCT), real world data, sensors and wearables, and randomization and trial supply management (RTSM).

Senti Biosciences, Inc. announced that effective on February 1, 2023, the Compensation Committee of Senti Bio’s Board of Directors granted to 13 new employees stock options to purchase an aggregate of 309,000 shares of the Company’s common stock with a per share exercise price of $1.81.

Arcutis Biotherapeutics, Inc. reported the grant of an aggregate of 50,250 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 8,000 shares of Arcutis’ common stock to seven newly hired employees.

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, and antibiotic resistance genes, announced that it issued inducement awards to fourteen new employees.

DURECT Corporation announced that it has entered into a definitive agreement with a leading institutional healthcare investor and an existing institutional investor for the purchase and sale of an aggregate of 1,700,000 shares of common stock and, in lieu of shares of common stock, pre-funded warrants to purchase 300,000 shares of common stock, and accompanying warrants to purchase up to 2,000,000 shares of common stock in a registered direct offering.

Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) announces that it has granted an aggregate of 6,065,000 options to purchase common shares of the Company

Sorrento Therapeutics, Inc. distributed dividend confirmation statements to 146 brokerage firms regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento.

Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability milestone

Dexlevo, a company specializing in aesthetic medical devices, successfully held a symposium dedicated to its exclusive product, ‘GOURI’, at the IMCAS World Congress 2023 in Paris.